Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS).
Chen CH, Elsalmawy AH, Ish-Shalom S, Lim SJ, AlAli NS, Cunha-Borges JL, Yang H, Casas N, Altan L, Belaya Z, Marin F, Moll T, Gurbuz S, Brnabic A, Pavo I, Florez S. Chen CH, et al. Among authors: marin f. Calcif Tissue Int. 2022 Jan;110(1):74-86. doi: 10.1007/s00223-021-00895-4. Epub 2021 Aug 20. Calcif Tissue Int. 2022. PMID: 34415388 Free PMC article.
Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).
Langdahl BL, Ljunggren Ö, Benhamou CL, Marin F, Kapetanos G, Kocjan T, Lespessailles E, Napoli N, Nikolic T, Petto H, Moll T, Lindh E. Langdahl BL, et al. Among authors: marin f. Calcif Tissue Int. 2016 Sep;99(3):259-71. doi: 10.1007/s00223-016-0143-5. Epub 2016 Apr 30. Calcif Tissue Int. 2016. PMID: 27137783 Free PMC article.
Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS).
Napoli N, Langdahl BL, Ljunggren Ö, Lespessailles E, Kapetanos G, Kocjan T, Nikolic T, Eiken P, Petto H, Moll T, Lindh E, Marin F. Napoli N, et al. Among authors: marin f. Calcif Tissue Int. 2018 Oct;103(4):359-371. doi: 10.1007/s00223-018-0437-x. Epub 2018 Jun 16. Calcif Tissue Int. 2018. PMID: 29909449 Free PMC article.
Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS).
Chen CH, Elsalmawy AH, Ish-Shalom S, Lim SJ, Al-Ali NS, Cunha-Borges JL, Yang H, Casas N, Altan L, Moll T, Gurbuz S, Brnabic AJM, Burge RT, Marin F. Chen CH, et al. Among authors: marin f. Curr Med Res Opin. 2019 Jun;35(6):1041-1049. doi: 10.1080/03007995.2018.1552576. Epub 2019 Jan 3. Curr Med Res Opin. 2019. PMID: 30474449
Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS).
Langdahl BL, Rajzbaum G, Jakob F, Karras D, Ljunggren O, Lems WF, Fahrleitner-Pammer A, Walsh JB, Barker C, Kutahov A, Marin F. Langdahl BL, et al. Among authors: marin f. Calcif Tissue Int. 2009 Dec;85(6):484-93. doi: 10.1007/s00223-009-9299-6. Epub 2009 Oct 13. Calcif Tissue Int. 2009. PMID: 19823760 Free PMC article.
Effectiveness of Teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS).
Walsh JB, Lems WF, Karras D, Langdahl BL, Ljunggren O, Fahrleitner-Pammer A, Barrett A, Rajzbaum G, Jakob F, Marin F. Walsh JB, et al. Among authors: marin f. Calcif Tissue Int. 2012 May;90(5):373-83. doi: 10.1007/s00223-012-9590-9. Epub 2012 Apr 1. Calcif Tissue Int. 2012. PMID: 22466444 Free PMC article.
1,132 results